Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 4, 2016
Neoadjuvant chemotherapy in ovarian cancer revisitedS Mahner, F Trillsch, D Chi, et al.
Geburtshilfe Und Frauenheilkunde|April 29, 2014
Statement by the Kommission OVAR of the AGO Study Group on the Use of HIPEC (Hyperthermic Intraperitoneal Chemotherapy) to Treat Primary and Recurrent Ovarian CancerP Harter, S Mahner, F Hilpert, et al.
Journal of Gynecology Obstetrics and Human Reproduction|April 22, 2023
Amniotic fluid embolism: A comparison of two classification systems in a retrospective 8-year analysis from two tertiary hospitalsJ Buechel, C Monod, I Alba Alejandre, et al.
Archives of Gynecology and Obstetrics|March 28, 2026
Tumor biology, treatment patterns, and recurrence in breast cancer patients aged 70-79 vs ≥ 80 years: a large-scale registry analysisF Ganster, S Schrodi, M Braun, et al.
Journal of Clinical Pathology|December 1, 2011
EGFR gene copy number increase in vulvar carcinomas is linked with poor clinical outcomeL Woelber, S Hess, H Bohlken, et al.
Journal of Reproductive Immunology|April 1, 2026
Placental immune cell distributions of CD4, CD8 and CD56 in the context of SARS-CoV-2 infection and vaccinationF Ganster, C Hafner, L Hahn, et al.
Geburtshilfe Und Frauenheilkunde|March 5, 2016
Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria and AGO Switzerland Regarding the Use of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian CancerP Harter, A du Bois, S Mahner, et al.
Archives of Gynecology and Obstetrics|December 11, 2023
Management of non-tubal ectopic pregnancies analysis of a large tertiary center case seriesE Tremmel, T Starrach, C Buschmann, et al.
British Journal of Cancer|November 19, 2009
Assessment of residual tumour by FDG-PET: conventional imaging and clinical examination following primary chemotherapy of large and locally advanced breast cancerJ Dose-Schwarz, R Tiling, S Avril-Sassen, et al.
Cancer Chemotherapy and Pharmacology|January 22, 2009
Pegylated liposomal doxorubicin (CAELYX) in patients with advanced ovarian cancer: results of a German multicenter observational studyJalid Sehouli, O Camara, M Schmidt, et al.
Pageof 5